Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 142 shares at $143.47 ($20K) on 2023-08-29, disclosed to the SEC on 2023-08-31.
Seasonal sale ($20k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |